Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intestinal Lavage for Severe C. Difficile
NCT02466698Phase 3Unknown
- Start
- Aug 2016
- Primary completion
- Aug 2019
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 3 trial of polyethylene glycol 3350 in Clostridium difficile infection (CDI). Status: unknown.
02
Drugs
polyethylene glycol 3350
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02466698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466698.